Color 3D PrintingMedical AMMedical Models

Ricoh 3D for Healthcare and SimBioSys 3D print cancer models

Leveraging AI and computational modeling to aid the treatment of breast cancer

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Ricoh USA, via its Ricoh 3D for Healthcare business, a leader in the manufacturing of patient-specific medical devices, and SimBioSys, a TechBio company leveraging AI and computational modeling, have entered a collaboration to explore cutting-edge technologies with the potential to aid the treatment of breast cancer. This collaboration aims to evaluate the potential of AI with advanced 3D printing to help improve surgical experiences and personalize patient care for breast cancer.

SimBioSys, known for its revolutionary TumorSight platform, the first digital precision medicine platform, and Ricoh 3D for Healthcare are set to showcase the potential of their combined technologies. The vision for this collaboration is to help create a transformative approach to breast cancer treatment – integrating SimBioSys’ AI capabilities with Ricoh’s 3D printing expertise to produce highly accurate, patient-specific breast cancer models.

Ricoh 3D for Healthcare and SimBioSys will unveil some of their first AI-generated, 3D printed breast cancer models at the upcoming American Society of Breast Surgeons (ASBrS) conference. This event will serve as a platform to demonstrate the capabilities and potential of their integrated technologies to the breast surgeon community.

“Through a collaboration with SimBioSys, we hope to not just envision a new future for medical treatment but help actively create it,” said Gary Turner, Managing Director at Ricoh USA. “Our dedication to precision and personalization in breast cancer care is about to be showcased at ASBrS, reflecting the potential of our combined efforts.”

At the ASBrS conference, attendees will experience firsthand the potential benefits of a Ricoh-SimBioSys collaboration. “Our presence at ASBrS will be an excellent opportunity to demonstrate how this synergy has potential to benefit surgeons and patients by providing a clearer understanding of complex cancer surgeries before the first incision is made,” said Jyoti Palaniappan, Chief Commercial Officer at SimBioSys.

The integrated SimBioSys and Ricoh 3D for Healthcare workflow is currently for educational purposes only and not FDA-cleared (or otherwise cleared) for diagnostic use or other uses.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.